GB1293310A - Vaccine - Google Patents

Vaccine

Info

Publication number
GB1293310A
GB1293310A GB01385/71A GB1138571A GB1293310A GB 1293310 A GB1293310 A GB 1293310A GB 01385/71 A GB01385/71 A GB 01385/71A GB 1138571 A GB1138571 A GB 1138571A GB 1293310 A GB1293310 A GB 1293310A
Authority
GB
United Kingdom
Prior art keywords
virus
vaccine
varicella
tissue
april
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB01385/71A
Other languages
English (en)
Inventor
Maurice R Hilleman
Eugene B Buynak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1293310A publication Critical patent/GB1293310A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB01385/71A 1970-04-28 1971-04-26 Vaccine Expired GB1293310A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3276970A 1970-04-28 1970-04-28

Publications (1)

Publication Number Publication Date
GB1293310A true GB1293310A (en) 1972-10-18

Family

ID=21866708

Family Applications (1)

Application Number Title Priority Date Filing Date
GB01385/71A Expired GB1293310A (en) 1970-04-28 1971-04-26 Vaccine

Country Status (11)

Country Link
AT (1) AT303965B (cg-RX-API-DMAC7.html)
AU (1) AU2788871A (cg-RX-API-DMAC7.html)
BE (1) BE766333A (cg-RX-API-DMAC7.html)
DE (1) DE2120426A1 (cg-RX-API-DMAC7.html)
ES (1) ES390603A1 (cg-RX-API-DMAC7.html)
FR (1) FR2092100B1 (cg-RX-API-DMAC7.html)
GB (1) GB1293310A (cg-RX-API-DMAC7.html)
HU (1) HU163131B (cg-RX-API-DMAC7.html)
IL (1) IL36649A0 (cg-RX-API-DMAC7.html)
NL (1) NL7103524A (cg-RX-API-DMAC7.html)
ZA (1) ZA712711B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043847A4 (en) * 1980-01-25 1982-07-06 Wistar Inst HIGHLY ATTENUED CHICKENPOX VIRUS VACCINE AND PRODUCTION THEREOF.

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2952825B1 (fr) 2009-11-24 2012-05-25 Goaster Jacqueline Le Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043847A4 (en) * 1980-01-25 1982-07-06 Wistar Inst HIGHLY ATTENUED CHICKENPOX VIRUS VACCINE AND PRODUCTION THEREOF.

Also Published As

Publication number Publication date
AU2788871A (en) 1972-10-26
HU163131B (cg-RX-API-DMAC7.html) 1973-06-28
AT303965B (de) 1972-12-27
BE766333A (fr) 1971-10-27
NL7103524A (cg-RX-API-DMAC7.html) 1971-11-01
ES390603A1 (es) 1974-04-01
ZA712711B (en) 1972-12-27
DE2120426A1 (de) 1971-11-11
FR2092100B1 (cg-RX-API-DMAC7.html) 1974-08-30
FR2092100A1 (cg-RX-API-DMAC7.html) 1972-01-21
IL36649A0 (en) 1971-06-23

Similar Documents

Publication Publication Date Title
CESARIO et al. Six years experience with herpes simplex virus in a children's home
GB1457382A (en) Process for preparing live varticella vaccines
SE398504B (sv) Forfarande for framstellning av enzymberedningar bestaende av fasta sferer med jemn storlek
GB1501724A (en) Highly attenuated cytomegalovirus vaccine and production thereof
DK208987A (da) Polypeptider og antistoffer, som er karakteristiske for papillomvirus, og deres anvendelse ved diagnostiske metoder og i vacciner
EP0279563A3 (en) Influenza vaccine
GB1486186A (en) Vaccines against feline leukaemia and the group of diseases associated with feline leukaemis/virus infection
GB1293310A (en) Vaccine
Sheffield et al. The serial propagation of poliomyelitis viruses in cells derived from rabbit embryo kidney
GB1488800A (en) Influenza vaccines
GB1481650A (en) Chemical processes and products
GB1358321A (en) Method od tissue cell culture
IT1148013B (it) Procedimento per ottenere preparati di tossoplasmi per la diagnosi del la tossoplasmosi e preparati cosi' ottenuti
Weil et al. The type-specificity of immune protection against Shigella paradysenteriae (Flexner)
ES8107024A1 (es) Metodo para preparar una vacuna que contiene virus desacti- vado de peritonilis infecciosa felina.
Dzhivanyan et al. On the possible association of the DS marker of tick-borne encephalitis virus strains with species of tick vectors
GB1274820A (en) Highly attenuated newcastle disease virus vaccine and production thereof
GB1152607A (en) Antigenic Compositions
Graham et al. The toxicity of P32 for normal and influenza virus infected embryos
Weller et al. Biological characteristics of rubella virus as assayed in a human amnion culture system
ES392830A1 (es) Procedimiento para la preparacion de una vacuna oral contrael tifus.
GB1453035A (en) Virus vaccine production
ES437787A1 (es) Un procedimiento para la preparacion de un virus vivo ate- nuado de varicela.
GB1436323A (en) Cell and virus culture systems
GB1234718A (en) Vaccines

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLNP Patent lapsed through nonpayment of renewal fees